Prevalence of Hepatocellular Carcinoma; liver Cirrhosis and HBV Carriers in Liver Disease Patients Reffered to Clinical Research Centre; Kemri

The prevalence of HBsAg positivity; liver cirrhosis (LC) and hepatocellular carcinoma (HCC) is studied in 139 patients at the Clinical Research Centre of KEMRI. The prevalences were found to be 15.1; 9.3and 10respectively. 14of the HBsAg positives were also E antigen positive. The positivity of HBsAg in HCC was 42.9only 15.4in LC and 57.1HCC had AFP compared to only 15.4in LC. It is suggested that the findings support an association of Hepatitis B virus with LC and HCC